MYALGIA

Adverse reaction reported in 67,760 FDA reports across 40 drugs.

67,760

Total Reports

Drugs Involved

Atorvastatin

Most Reported Drug

Drugs Associated with MYALGIA

Drugs where "MYALGIA" was reported as an adverse event.

#	Drug	Reports	% of Total
1	Atorvastatin	9,889	14.6%
2	Rosuvastatin	8,941	13.2%
3	Simvastatin	8,387	12.4%
4	Evolocumab	5,332	7.9%
5	Ezetimibe	4,379	6.5%
6	Denosumab	4,202	6.2%
7	Ciprofloxacin	2,765	4.1%
8	Teriparatide	2,547	3.8%
9	Ciprofolxacin	2,315	3.4%
10	Selexipag	1,967	2.9%
11	Zoledronic Acid	1,832	2.7%
12	Alirocumab	1,667	2.5%
13	Anastrozole	1,061	1.6%
14	Ofatumumab	889	1.3%
15	Fenofibrate	884	1.3%
16	Nilotinib	825	1.2%
17	Pitavastatin	823	1.2%
18	Relugolix	772	1.1%
19	Abaloparatide	701	1.0%
20	Ezetimibe / Simvastatin	672	1.0%
21	Pravastatin	649	1.0%
22	Dasatinib	585	0.9%
23	Lovastatin	557	0.8%
24	Telmisartan	506	0.7%
25	Sofosbuvir	487	0.7%
26	Imatinib	443	0.7%
27	Dutasteride	432	0.6%
28	Gemfibrozil	420	0.6%
29	Vemurafenib	354	0.5%
30	Niacin	326	0.5%
31	Omega-3-Acid Ethyl Esters	322	0.5%
32	Colesevelam	296	0.4%
33	Brinzolamide	271	0.4%
34	Ledipasvir / Sofosbuvir	230	0.3%
35	Vismodegib	213	0.3%
36	Asfotase Alfa	196	0.3%
37	Romosozumab-Aqqg	185	0.3%
38	Acalabrutinib	175	0.3%
39	Encorafenib	158	0.2%
40	Nemolizumab-Ilto	105	0.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused myalgia. Always consult your healthcare provider.